Total Payments
$12,856
2024 Payments
$2,144
Companies
35
Transactions
608
Medicare Patients
2,886
Medicare Billing
$232,672
Payment Breakdown by Category
Food & Beverage$12,651 (98.4%)
Education$205.52 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,651 | 593 | 98.4% |
| Education | $205.52 | 15 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,426 | 122 | $0 (2024) |
| Novo Nordisk Inc | $2,106 | 103 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,398 | 55 | $0 (2024) |
| Amgen Inc. | $1,209 | 54 | $0 (2024) |
| Merck Sharp & Dohme LLC | $915.41 | 52 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $800.29 | 38 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $697.63 | 36 | $0 (2024) |
| Lilly USA, LLC | $454.26 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $446.81 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $292.54 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,144 | 86 | Novo Nordisk Inc ($329.65) |
| 2023 | $1,479 | 65 | Novo Nordisk Inc ($211.93) |
| 2022 | $1,427 | 66 | AstraZeneca Pharmaceuticals LP ($234.69) |
| 2021 | $1,312 | 62 | Amgen Inc. ($191.37) |
| 2020 | $1,054 | 53 | Novo Nordisk Inc ($247.39) |
| 2019 | $1,829 | 87 | AstraZeneca Pharmaceuticals LP ($550.23) |
| 2018 | $1,833 | 93 | AstraZeneca Pharmaceuticals LP ($516.95) |
| 2017 | $1,780 | 96 | AstraZeneca Pharmaceuticals LP ($362.79) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.44 | General |
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: DIABETES | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: DIABETES | ||||||
| 08/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $29.30 | General |
| Category: Insulin Pump | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 703 | 1,214 | $105,183 | $60,916 |
| 2022 | 14 | 711 | 1,212 | $96,762 | $59,569 |
| 2021 | 13 | 778 | 1,271 | $97,038 | $61,016 |
| 2020 | 12 | 694 | 1,156 | $87,848 | $51,170 |
Total Patients
2,886
Total Services
4,853
Medicare Billing
$232,672
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 441 | $51,208 | $29,034 | 56.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 46 | 47 | $12,714 | $7,707 | 60.6% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 21 | 38 | $6,897 | $4,699 | 68.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $4,944 | $4,534 | 91.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 15 | $3,455 | $2,300 | 66.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 23 | $3,775 | $2,092 | 55.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 26 | 26 | $5,200 | $1,784 | 34.3% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 21 | 21 | $2,681 | $1,662 | 62.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 110 | 190 | $1,900 | $1,596 | 84.0% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 21 | 21 | $2,655 | $1,469 | 55.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 40 | 40 | $2,985 | $1,269 | 42.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 45 | $1,179 | $1,138 | 96.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 79 | $1,621 | $752.91 | 46.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 106 | 171 | $3,420 | $583.11 | 17.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 13 | $330.85 | $199.50 | 60.3% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 11 | 13 | $218.92 | $96.64 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 407 | $45,092 | $27,064 | 60.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 49 | 53 | $13,906 | $9,049 | 65.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 25 | 43 | $7,290 | $5,562 | 76.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 26 | 26 | $6,500 | $5,161 | 79.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 25 | 25 | $4,169 | $2,996 | 71.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 16 | $3,489 | $2,702 | 77.4% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 25 | 25 | $2,864 | $1,996 | 69.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 96 | 121 | $2,353 | $1,078 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $2,054 | $934.25 | 45.5% |
About Dr. Shaheed Khan, MD
Dr. Shaheed Khan, MD is a Internal Medicine healthcare provider based in Springfield Gardens, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427066414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shaheed Khan, MD has received a total of $12,856 in payments from pharmaceutical and medical device companies, with $2,144 received in 2024. These payments were reported across 608 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($12,651).
As a Medicare-enrolled provider, Khan has provided services to 2,886 Medicare beneficiaries, totaling 4,853 services with total Medicare billing of $232,672. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Springfield Gardens, NY
- Active Since 08/04/2006
- Last Updated 01/03/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427066414
Products in Payments
- FARXIGA (Drug) $1,845
- JARDIANCE (Drug) $1,206
- Ozempic (Drug) $927.56
- Otezla (Drug) $532.15
- ENTRESTO (Drug) $449.23
- Kerendia (Drug) $446.81
- JANUVIA (Drug) $394.82
- SOLIQUA 100/33 (Biological) $370.76
- Aimovig (Biological) $352.41
- VERQUVO (Drug) $335.88
- Vascepa (Drug) $292.54
- Rybelsus (Drug) $286.97
- BREZTRI (Drug) $276.00
- LEQVIO (Drug) $248.40
- Victoza (Drug) $231.06
- Tresiba (Drug) $210.79
- SYMBICORT (Drug) $198.14
- ELIQUIS (Drug) $196.76
- SOLIQUA (Drug) $195.75
- AFREZZA (Drug) $183.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.